Incompatible kidney transplantation: a brief overview of the past, present and future
Open Access
- 19 August 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 105 (12) , 1141-1150
Abstract
Live kidney donor transplantation across immunological barriers, either blood group or positive crossmatch [ABO- and human leucocyte antigens (HLA)-incompatible kidney transplantation, respectively], is now practised widely across many transplant centres. This provides transplantation opportunities to patients that hitherto would have been deemed contra-indicated and would subsequently have waited indefinitely for a suitably matched kidney. Protocols have evolved with time as experience has grown and now a variety of desensitization strategies are currently practised to overcome such immunological barriers. In addition, desensitization protocols are complemented by kidney paired donation exchange schemes and therefore incompatible patients now have strategies to either confront or bypass immunological barriers, respectively. As the field expands it is clear that non-transplant clinicians will be exposed to incompatible kidney transplant recipients outside of experienced centres. It is therefore timely to review the evolution of practice that have led to current desensitization modalities, contrast protocols and outcomes of current regimens and speculate on future direction of incompatible kidney transplantation.Keywords
This publication has 51 references indexed in Scilit:
- Outcomes of ABO-Incompatible Kidney Transplantation in the United StatesTransplantation, 2012
- Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous ImmunoglobulinClinical Journal of the American Society of Nephrology, 2011
- Incompatible Live-Donor Kidney Transplantation in the United StatesClinical Journal of the American Society of Nephrology, 2011
- Quantifying HLA-specific antibodies in patients undergoing desensitizationCurrent Opinion in Organ Transplantation, 2011
- B-cell immunotherapeuticsCurrent Opinion in Organ Transplantation, 2011
- Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantationTransplant Immunology, 2011
- The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab InductionTransplantation, 2011
- Accommodation in renal transplantation: unanswered questionsCurrent Opinion in Organ Transplantation, 2010
- Successful Combined Partial Auxiliary Liver and Kidney Transplantation in Highly Sensitized Cross-Match Positive RecipientsAmerican Journal of Transplantation, 2007
- Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodiesTransplant Immunology, 1994